Showing 1 - 10 of 140
We investigate the adaptation of random boolean networks that are a model for regulatory gene networks. The model …
Persistent link: https://www.econbiz.de/10010873785
Synthetic genetic circuits are artificial networks of transcriptional control elements inserted into living cells in order to 'program' cellular behavior. We can extend this application to programming population behavior by incorporating cell-cell communications capabilities. By designing and...
Persistent link: https://www.econbiz.de/10005080951
A gene regulatory network depicts which genes turn on which and at what moment. Knowledge of such gene networks is key … to an understanding of the biological process. We propose here to use a statistical method for the reconstruction of gene … regulatory networks based on Bayesian networks from microarray data. We describe a nonlinear model for the rate of gene …
Persistent link: https://www.econbiz.de/10010588441
&J), mRNA1273 (Moderna), BBIBP-CorV (Sinopharm/Beijing), Coronavac (Sinovac), Covaxin (Bharat/ICMR), and NVX-CoV2373 (Novavax …
Persistent link: https://www.econbiz.de/10012882660
Previous studies of genetic interactions have focused on measuring and analyzing the level of mRNA expressed by each … gene and then finding statistical correlations between them. Here we focus on assessing the global pattern, not the level … probability density function (PDF) of the mRNA levels produced by each model. Thus, we make a dictionary of the mRNA patterns …
Persistent link: https://www.econbiz.de/10010589497
The kinetics of gene expression can be bistable due to the feedback between the mRNA and protein formation. In …
Persistent link: https://www.econbiz.de/10010590279
infectious diseases, we simulate the financial performance of a hypothetical vaccine megafund consisting of 120 mRNA vaccine … may cause the next global pandemic. We calibrate the simulation parameters with input from domain experts in mRNA … investment of −6.0% per annum and a negative net present value of −$9.5 billion, despite the scientific advantages of mRNA …
Persistent link: https://www.econbiz.de/10014343742
&J), mRNA1273 (Moderna), BBIBP-CorV (Sinopharm/Beijing), Coronavac (Sinovac), Covaxin (Bharat/ICMR), and NVX-CoV2373 (Novavax …
Persistent link: https://www.econbiz.de/10012818093
We analyze the financial performance of a hypothetical portfolio of 120 mRNA vaccine candidates in the preclinical … mRNA technology and an extensive literature review. We find that the portfolio generates an average annualized return on … investment of -6.0% per annum and a net present value of -$9.5 billion, despite the scientific advantages of mRNA technology and …
Persistent link: https://www.econbiz.de/10013334345
In this contribution we illustrate some applications of the theory of dynamical systems with parameteric and interval uncertainties to the analysis of limiting behaviour and stability of some neokeynesian macroeconomic models considered in [6]. The analysis is based on linearization of the...
Persistent link: https://www.econbiz.de/10008528829